Asymmetric sensorineural hearing loss — suspected vestibular schwannoma
ACR AC Hearing Loss and/or Vertigo; ACR AC TinnitusA targeted internal auditory meatus study, not a brain scan and not a temporal bone CT. The lesion being sought is often only a few millimetres and sits inside a canal that routine brain sequences do not resolve.
Audiometrically confirmed asymmetric sensorineural hearing loss, unilateral tinnitus without a conductive or pulsatile explanation, or unexplained unilateral vestibular failure.
Referenced decision support — confirm against your local protocol.
Decision support, not a directive. Protocols and timings shown are typical published ones — your local protocol takes precedence, and the vetting radiologist decides.
- A small intracanalicular schwannoma is a millimetric filling defect within the cerebrospinal fluid of the internal auditory canal, and resolving it requires submillimetre sections targeted at the canal rather than whole-brain coverage. Contrast adds the intralabyrinthine and neuritic causes that a fluid-sensitive screen alone cannot show, and it separates a small tumour from a vascular loop or a normal nerve bundle. Contrast-enhanced CT is markedly less sensitive for this region and does not substitute.
Nothing needs resolving before this goes ahead. Routine checks below are owned downstream.
How was this decided?
- pathwayadult — Adults
- rulerule-mr-device-screening — MR safety screening for implants and foreign bodies; checked by Radiographer at the scanner
- rulerule-contrast-reaction-premed — Prior contrast reaction and elective premedication; checked by Nurse before the scan
- rulerule-gadolinium-renal — Kidney function and gadolinium-based contrast; checked by Radiographer at the scanner
- rulerule-pregnancy-gadolinium — Gadolinium in known or possible pregnancy; checked by Radiographer at the scanner
- rulerule-iv-access — Intravenous access adequate for the planned injection; checked by Radiographer at the scanner
Decision support only. Local protocol takes precedence.
Handled at the scanner(2)nothing for you to do
Settled and owned downstream. Each returns to a radiologist only on the stated trigger.
- MR safety screening for implants and foreign bodiesComplete the MR safety questionnaire, verify implant labelling and its stated conditions of use against this scanner and this protocol, and ensure no ferromagnetic object enters Zone IV.Radiographer at the scannerBefore the scanFlags back if: An implant or retained foreign body that is MR Unsafe, unlabelled, or cannot be identified; or an MR Conditional device whose stated conditions this scanner or the requested protocol cannot satisfy; or a credible unexcluded intraocular metallic foreign body history.
- Intravenous access adequate for the planned injectionSite and test a cannula that supports the protocol flow rate, preferring an antecubital or large forearm vein, and observe the injection for extravasation. A 20-gauge or larger cannula is preferred for flow rates of 3 mL/s or more.Radiographer at the scannerAt the scannerFlags back if: No cannula can be sited that supports the protocol flow rate — for example only a 22-gauge hand or foot cannula for a CT angiogram needing 4–5 mL/s; or the only available access is a central line or port that is not labelled power-injectable; or an extravasation occurs.
Pathways
Big forks are separate pathways; the first whose conditions match is the one used.
Adults
Matches your inputsDefault| Role | Study & protocol | Why this answers the question |
|---|---|---|
| First line | MRI Internal Auditory Meati / Cerebellopontine Angles MRI IAM — with gadolinium usually appropriate | A small intracanalicular schwannoma is a millimetric filling defect within the cerebrospinal fluid of the internal auditory canal, and resolving it requires submillimetre sections targeted at the canal rather than whole-brain coverage. Contrast adds the intralabyrinthine and neuritic causes that a fluid-sensitive screen alone cannot show, and it separates a small tumour from a vascular loop or a normal nerve bundle. Contrast-enhanced CT is markedly less sensitive for this region and does not substitute. |
| Reasonable alternative | MRI Internal Auditory Meati / Cerebellopontine Angles MRI IAM — unenhanced high-resolution screen | A high-resolution heavily T2-weighted screen without gadolinium is widely used as the first study for this question and has high sensitivity for a schwannoma large enough to matter, at no contrast exposure and in a shorter slot. Its weakness is the non-mass causes — labyrinthitis, neuritis, intralabyrinthine tumour — which is exactly why an abnormal or unexplained screen is completed with contrast rather than reported as negative. |
| Problem solving | CT Temporal Bones CT Temporal Bones — High Resolution | Belongs to the conductive and mixed loss question rather than this one: ossicular pathology, otosclerosis, cholesteatoma, congenital anomaly and post-traumatic loss. It is also the planning study before cochlear implantation. It cannot assess the eighth nerve and does not answer asymmetric sensorineural loss. |
Pitfalls
- Booking a routine brain MRI, whose slice thickness cannot exclude a small intracanalicular lesion.
- Reporting a negative unenhanced screen as excluding all causes when labyrinthitis and intralabyrinthine schwannoma need contrast to be seen.
- Requesting temporal bone CT for a sensorineural loss, which answers a different anatomical question entirely.
- Missing bilateral lesions and the wider implication of neurofibromatosis type 2 in a younger patient.
- Overlooking sudden sensorineural hearing loss as a presentation of anterior inferior cerebellar artery territory infarction, where the brain sequences matter as much as the canal.
- Letting the scan set the pace in sudden sensorineural hearing loss. Corticosteroid treatment is time-dependent and started on the audiogram; the imaging runs alongside it, and a waiting-list slot for the internal auditory meati is not a reason for anyone to wait.
Priors — what to pull first
- For a known schwannoma on surveillance, measure on the same plane and in the same axis as the previous study; growth is a millimetre-scale judgement.
- After radiosurgery, transient central loss of enhancement and modest swelling are expected and are not progression.
What makes a good request
- Include the audiogram result and which ear. Asymmetry is defined audiometrically, and a request without it cannot be triaged.
- There is a real difference in practice between guideline bodies here. The ACR rates MRI of the internal auditory canals without and with contrast as the most appropriate initial study, while many centres screen with high-resolution heavily T2-weighted sequences alone and reserve gadolinium for an abnormal or equivocal screen. Both are defensible; local policy should decide, and the card records the divergence rather than hiding it.
- Pulsatile tinnitus is a different question with a vascular differential and does not belong on this pathway.
- Sudden sensorineural hearing loss is an otological emergency and a different clock from the elective asymmetry question. Corticosteroid treatment is started within days on audiometric confirmation and must not wait for a scan, and the imaging is arranged alongside it rather than in front of it. Where the sudden loss comes with vertigo, ataxia or any other neurological sign, the differential includes labyrinthine or anterior inferior cerebellar artery infarction — that patient needs brain sequences with diffusion in the same study, and a prodromal sudden deafness preceding a full cerebellar infarct is a recognised and repeatedly missed pattern.
Scoring this once it is done
The classification and risk tools this question ends in.
How these studies are acquired
Contrast, phases and timing for every study on the pathways above.
Confirm locally
- MRI IAM — with gadolinium: timings are typical — confirm against local protocol.
- Timings, contrast volumes and rates above are typical published values. Your department's protocol, scanner and patient population decide the actual numbers.
- Safety thresholds and premedication policy follow local policy where it differs from the cited guidance.
References
- ACR Appropriateness Criteria — Hearing Loss and/or Vertigo · ACR Appropriateness Criteria
- ACR Appropriateness Criteria — Tinnitus · ACR Appropriateness Criteria
- American College of Radiology Manual on MR Safety: 2024 Update and Revisions. Radiology. · ACR MR Safety
- ACR Manual on MR Safety — zoning, MR Safe / MR Conditional / MR Unsafe labelling, and screening of patients and personnel · ACR MR Safety
- Safety of MRI in patients with cardiac implantable electronic devices — conditions of use, device interrogation and monitoring · Primary literature
- ACR Manual on Contrast Media — premedication regimens (elective oral prednisone 50 mg at 13/7/1 h plus diphenhydramine 50 mg at 1 h; methylprednisolone 32 mg at 12 and 2 h; accelerated IV hydrocortisone 200 mg or methylprednisolone 40 mg every 4 h; regimens under 4–5 h lack evidence of efficacy) · ACR Contrast Manual
- Management and Prevention of Hypersensitivity Reactions to Radiocontrast Media: A Consensus Statement from the ACR and the AAAAI. J Allergy Clin Immunol Pract, 2025. · Primary literature
- Schabelman E, Witting M. The relationship of radiocontrast, iodine and seafood allergies: a medical myth exposed. J Emerg Med. · Primary literature
- CAR/CSACI Practice Guidance for Contrast Media Hypersensitivity (2025) · Other
- Weinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, Perazella MA, Dillman JR, Davenport MS. Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the ACR and the National Kidney Foundation. — Group II NSF risk: 0 events in 4931 administrations at eGFR <30; upper 95% CI bounds 0.07% overall, 0.2% CKD 5D, 0.5% CKD 5 non-dialysis · ACR/NKF consensus
- Woolen SA et al. Risk of NSF in patients with stage 4 or 5 CKD receiving a group II GBCA: systematic review and meta-analysis. JAMA Intern Med. · Primary literature
- ESUR Contrast Media Guidelines v10.0 — gadolinium agents and NSF risk classification — European practice diverges: after the EMA Article 31 referral the marketing authorisations of several intravenous linear agents (gadodiamide, gadopentetate, gadoversetamide) were suspended, so the ACR "group I" discussion is largely moot in the EU/UK while remaining live in the US · ESUR
- EMA — gadolinium-containing contrast agents Article 31 referral: PRAC confirms restrictions on linear agents · Other
- Contrast Media in Pregnant and Lactating Patients — AJR Special Series on Contrast Media · Primary literature
- ACOG Committee Opinion — Guidelines for Diagnostic Imaging During Pregnancy and Lactation · Other
- ACR-SPR Practice Parameter for the Use of Intravascular Contrast Media · Other
- Behrendt FF et al. Peripheral intravenous power injection of iodinated contrast media through 22G and 20G cannulas: can high flow rates be achieved safely? A clinical feasibility study. · Primary literature
- Pressure injectors for radiologists: a review — extravasation incidence and catheter/flow-rate relationships · Primary literature
Implemented from the cited published sources. Educational and workflow support only; confirm against current guidelines and local policy before clinical use.